GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $669,000 | +0.5% | 15,375 | +0.5% | 0.01% | 0.0% |
Q1 2022 | $666,000 | -9.0% | 15,301 | -7.8% | 0.01% | -7.1% |
Q4 2021 | $732,000 | +23.2% | 16,595 | +6.7% | 0.01% | +16.7% |
Q3 2021 | $594,000 | -0.3% | 15,557 | +3.9% | 0.01% | -14.3% |
Q2 2021 | $596,000 | +25.7% | 14,974 | +12.8% | 0.01% | -39.1% |
Q1 2021 | $474,000 | -1.2% | 13,270 | +1.7% | 0.02% | -8.0% |
Q4 2020 | $480,000 | +22.8% | 13,054 | +25.7% | 0.02% | -16.7% |
Q3 2020 | $391,000 | +1.0% | 10,388 | +9.6% | 0.03% | -18.9% |
Q2 2020 | $387,000 | -23.5% | 9,476 | -29.1% | 0.04% | -24.5% |
Q1 2020 | $506,000 | +36.8% | 13,360 | +69.8% | 0.05% | +40.0% |
Q4 2019 | $370,000 | +13.8% | 7,869 | +3.2% | 0.04% | 0.0% |
Q3 2019 | $325,000 | +24.0% | 7,622 | +16.3% | 0.04% | +25.0% |
Q2 2019 | $262,000 | +11.0% | 6,554 | -1.6% | 0.03% | -42.9% |
Q4 2017 | $236,000 | +9.3% | 6,662 | +33.0% | 0.05% | -3.9% |
Q2 2017 | $216,000 | +2.4% | 5,008 | +0.2% | 0.05% | -16.4% |
Q1 2017 | $211,000 | -0.9% | 4,998 | -4.9% | 0.06% | -12.9% |
Q1 2016 | $213,000 | +1.4% | 5,256 | +0.8% | 0.07% | 0.0% |
Q4 2015 | $210,000 | – | 5,215 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |